Caronti B, Palladini G, Bevilacqua M G, Petrangeli E, Fraioli B, Cantore G, Tamburrano G, Carapella C M, Jaffrain-Rea M L
Department of Neurological Sciences, University La Sapienza, Rome, Italy.
Tumour Biol. 1993;14(1):59-68. doi: 10.1159/000217826.
Six human pituitary adenoma cultures, characterized for estrogen and progesterone (Pg) receptors, were treated with 17 beta-estradiol (17 beta-E2), Pg and tamoxifen (TAM) at different concentrations, alone and in combination, for 2, 4 and 8 days. Cell proliferation data showed in most cases a stimulating effect of 17 beta-E2 and an inhibitory effect of Pg on cell growth, which appeared to be correlated with specific receptor expression, but independent of pituitary cell hormone content. A marked inhibitory effect of TAM on cell proliferation was present in all cases, but, on the contrary, was independent of estrogen receptor expression.
六种经雌激素和孕激素(Pg)受体特征化的人垂体腺瘤培养物,分别用不同浓度的17β-雌二醇(17β-E2)、Pg和他莫昔芬(TAM)单独及联合处理2天、4天和8天。细胞增殖数据显示,在大多数情况下,17β-E2具有刺激作用,Pg对细胞生长具有抑制作用,这似乎与特异性受体表达相关,但与垂体细胞激素含量无关。在所有情况下,TAM对细胞增殖均有显著抑制作用,但相反,其与雌激素受体表达无关。